Company intelligence / Profile preview

Guoxin Pharmaceutical Technology

Ownership: Private
Employees: ~500
Development stage: Other

Overview

Guoxin Pharmaceutical is a leading Chinese Contract Research Organization (CRO) providing comprehensive clinical research services to the pharmaceutical and biotechnology industries. The company specializes in clinical trial management, regulatory affairs, medical writing, and data management for both domestic and international drug development projects. With a strong focus on quality compliance and efficient project execution, Guoxin Pharmaceutical supports clients through all phases of clinical development, from Phase 1 through Phase 4, as well as bioequivalence studies. The firm is recognized for its expertise in navigating the complex regulatory landscape of the National Medical Products Administration (NMPA) in China.

Industry: Contract Research Organization

Beyond the preview

Go deeper on Guoxin Pharmaceutical Technology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Guoxin Pharmaceutical Technology.

Explore the full profile